RAPID ADOPTION OF PNEUMOCOCCAL 20-VALENT CONJUGATE VACCINE (PCV20) VACCINATION IN ADULT PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Karime, Christian
Crosby, Sheena K.
Bhat, Shubha
Hashash, Jana G.
Farraye, Francis A.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1781
引用
收藏
页码：S678 / S679
页数：2
相关论文
共 50 条
  • [1] The 20-valent pneumococcal conjugate vaccine (PCV20): expected added value
    Janssens, Esther
    Flamaing, Johan
    Vandermeulen, Corinne
    Peetermans, Willy E.
    Desmet, Stefanie
    De Munter, Paul
    ACTA CLINICA BELGICA, 2023, 78 (01) : 78 - 86
  • [2] Rapid Adoption of Pneumococcal 20-Valent Conjugate Vaccination in Adult Patients With Inflammatory Bowel Disease: An Analysis One Year After Availability
    Karime, Christian
    Crosby, Sheena
    Bhat, Shubha
    Hashash, Jana G.
    Farraye, Francis A.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (02) : 207 - 209
  • [3] Improving Vaccine Uptake of the Pneumococcal 20-valent Conjugate Vaccine (PCV20) in Young Rheumatic Disease Patients Using a Brief Intense Partnership Program
    Pasch, Kelsey
    Lindsey, Stephen
    Ferguson, Takeda
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2161 - 2163
  • [4] Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age
    Hurley, Donald
    Griffin, Carl
    Young, Mariano, Jr.
    Scott, Daniel A.
    Pride, Michael W.
    Scully, Ingrid L.
    Ginis, John
    Severs, Joseph
    Jansen, Kathrin U.
    Gruber, William C.
    Watson, Wendy
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E1489 - E1497
  • [5] UPTAKE OF 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV20) AMONG UNITED STATES (US) ADULTS FOLLOWING 2022 UPDATE TO RECOMMENDATIONS
    Averin, A.
    Vietri, J.
    Mohs, Arguedas A.
    Kaliasethi, A.
    Willis, S. J.
    Lonshteyn, A.
    Weycker, D.
    VALUE IN HEALTH, 2024, 27 (06) : S166 - S166
  • [6] Cost-Effectiveness of Vaccination with the 20-Valent Pneumococcal Conjugate Vaccine in the Italian Adult Population
    Polistena, Barbara
    Icardi, Giancarlo
    Orsi, Andrea
    Spandonaro, Federico
    Di Virgilio, Roberto
    d'Angela, Daniela
    VACCINES, 2022, 10 (12)
  • [7] Safety review of 20-valent pneumococcal conjugate vaccine
    Reactions Weekly, 2024, 2039 (1) : 9 - 9
  • [8] 20-Valent Pneumococcal Conjugate Vaccine: Pediatric First Approval
    Shirley, Matt
    PEDIATRIC DRUGS, 2023, 25 (05) : 613 - 619
  • [9] Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS)Post-licensure Safety of 20-Valent Pneumococcal Conjugate Vaccine in VAERSM. Oliveira et al.
    Mayra Oliveira
    Paige Marquez
    Carol Ennulat
    Phillip Blanc
    Kerry Welsh
    Narayan Nair
    Monica Taminato
    Pedro L. Moro
    Drug Safety, 2025, 48 (3) : 279 - 286
  • [10] 20-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults
    Shirley, Matt
    DRUGS, 2022, 82 (09) : 989 - 999
12345